聚焦进博会｜进口人工心脏、三尖瓣加速入华 心血管医疗器械赛道活跃

Core Insights - The cardiovascular medical device sector is highly competitive, with major multinational companies like Johnson & Johnson, Medtronic, Abbott, and Boston Scientific actively showcasing their innovations at the China International Import Expo (CIIE) [1][2][3] Group 1: Johnson & Johnson's Innovations - Johnson & Johnson's Impella device, an interventional artificial heart device, is nearing the final registration stage in China, expected to be approved by the end of this year or early next year [1] - Impella is the only device globally approved by the FDA that has been shown to improve survival rates in patients with cardiogenic shock [1] - The company emphasizes that the CIIE serves as an accelerator for introducing advanced medical technologies to China, garnering attention from regulatory bodies and healthcare professionals [1] Group 2: Competitive Landscape - Medtronic showcased a newly FDA-approved ultra-stiff guidewire, aimed at enhancing the stability and safety of transcatheter aortic valve replacement (TAVR) procedures, with plans to introduce it to the Chinese market [2] - The field of cardiac electrophysiology is witnessing the emergence of pulsed field ablation (PFA) technology, with multiple imported and domestic PFA products already approved in China, intensifying market competition [2] - Abbott presented the TriClip device for transcatheter heart valve repair, which has already been used in 10 patients in the Greater Bay Area and is expected to receive formal approval next year [3] Group 3: Technological Advancements - Siemens Healthineers introduced a DSA angiography device capable of generating 3D-like CT images in 2.5 seconds, integrating AI technologies for precise guidance in cardiovascular interventions [3] - The increasing display of advanced cardiovascular medical devices at the CIIE allows the public to engage with cutting-edge surgical equipment, highlighting the need for reasonable pricing models to make these therapies accessible to more patients [3]